Kohjin Bio Co., Ltd.
177A
Rank in Stocks
#26945
Kohjin Bio Co., Ltd., established in 1981 in Sakado, Japan, and known as Kohjin... Kohjin Bio Co., Ltd., established in 1981 in Sakado, Japan, and known as Kohjin Co.,Ltd. until its rebranding in 1989, is a diversified life science enterprise. The company's core business involves the production and sale of various biological materials, including animal blood, sera, cell culture media, agar media for microbial assays, in-vitro diagnostic products, and cosmetics. Its extensive catalog for cell and tissue culture features specialized mediums crucial for virus and recombinant protein synthesis, hybridoma development, human lymphocyte cultivation, and insect cell lines. Additionally, Kohjin Bio supplies complementary items such as gas-permeable cell culture bags, cryopreservation agents, medium supplements, normal human cells along with their growth media, ES cell media, and comprehensive kits for in-vitro fertilization and early embryo culture. The firm further provides essential laboratory tools like cell separation solutions, physiological salt solutions, and a range of research reagents. Within microbiology, Kohjin Bio offers a wide array of culture media tailored for various applications. For clinical diagnostics, this includes mediums for identifying gram-positive cocci and gram-negative bacteria, susceptibility testing, general differentiation, anaerobic growth, and fungal detection, alongside tube mediums for confirmatory tests and expansion. For food safety, their products cover sterilization assessments, and the detection of E. coli, coliform bacteria, Staphylococcus spp., Bacillus cereus, and Vibrio parahaemolyticus. The company also produces mediums for total viable cell count determination and specific media for Campylobacter and fungi. The company's blood and serum division offers normal human blood, serum, and plasma, as well as pathological human serum. Its animal blood portfolio encompasses preserved, defibrinated, and hemolyzed animal blood, in addition to animal serum and plasma, with custom-designed formulations like Eagle medium also available. Beyond its manufacturing activities, Kohjin Bio engages in the breeding and distribution of laboratory animals, the sale of medical equipment, and provides contract services for animal immunization and antibody preparation. The company also manages the import and export of its diverse products and raw materials internationally.
Share Price
$3.24
Last synced: 2026-11-19
Market Cap
$16.55M
Change (1 day)
-4.00%
Change (1 year)
-67.44%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Kohjin Bio Co., Ltd. (177A)
Category
Healthcare
Operating Margin for Kohjin Bio Co., Ltd. (177A)
Operating Margin as of November 2026 TTM: 3.32%
According to Kohjin Bio Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 3.32%. At the end of 2025 the company had an operating margin of 19.04%.
Operating Margin history for Kohjin Bio Co., Ltd. from 2022 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 3.32% | -82.56% |
| 2025 | 19.04% | 52.20% |
| 2024 | 12.51% | -53.18% |
| 2023 | 26.72% | 8.79% |
| 2022 | 24.56% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 33.87% | -89.80% |
US
|
|
| -116.04% | -134.95% |
US
|
|
| 25.57% | -92.30% |
AU
|
|
| 31.23% | -90.59% |
BE
|
|
| 29.35% | -91.16% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Kohjin Bio Co., Ltd.'s operating margin
What is Kohjin Bio Co., Ltd.'s operating margin?
Kohjin Bio Co., Ltd.'s operating margin is 3.32%, as of Nov 2026.
What was Kohjin Bio Co., Ltd.'s operating margin in 2025?
In 2025, Kohjin Bio Co., Ltd.'s operating margin was 19.04%, compared with 12.51% in 2024.
How has Kohjin Bio Co., Ltd.'s operating margin changed since 2022?
From 2022 to 2025, Kohjin Bio Co., Ltd.'s operating margin was highest in 2023 (26.72%) and lowest in 2024 (12.51%).
How does Kohjin Bio Co., Ltd.'s operating margin compare with similar companies?
Kohjin Bio Co., Ltd.'s operating margin (3.32%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.